These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 33369711)

  • 1. Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection.
    Song W; Zhang H; Zhang Y; Li R; Han Y; Lin Y; Jiang J
    Front Med; 2021 Jun; 15(3):404-415. PubMed ID: 33369711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for Zika drug discovery.
    Zou J; Shi PY
    Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zika virus outbreak: a review of neurological complications, diagnosis, and treatment options.
    Koppolu V; Shantha Raju T
    J Neurovirol; 2018 Jun; 24(3):255-272. PubMed ID: 29441490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Inhibitors of ZIKV Replication.
    Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika virus: The transboundary pathogen from mosquito and updates.
    Kong W; Li H; Zhu J
    Microb Pathog; 2018 Jan; 114():476-482. PubMed ID: 29241768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Agents in Development for Zika Virus Infections.
    Baz M; Boivin G
    Pharmaceuticals (Basel); 2019 Jun; 12(3):. PubMed ID: 31261947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural products as Zika antivirals.
    Fong YD; Chu JJH
    Med Res Rev; 2022 Sep; 42(5):1739-1780. PubMed ID: 35593443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of Doramectin as a New Anti-Zika Virus Agent.
    Zhu Y; Liang M; Yu J; Zhang B; Zhu G; Huang Y; He Z; Yuan J
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles.
    Brzuska G; Szewczyk B; Krol E
    Microbiol Spectr; 2023 Feb; 11(1):e0288522. PubMed ID: 36541807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on preclinical pregnancy models of Zika virus infection for drug and vaccine discovery.
    Benazzato C; Russo FB; Beltrão-Braga PCB
    Expert Opin Drug Discov; 2022 Jan; 17(1):19-25. PubMed ID: 34461793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika virus: an emerging challenge to public health worldwide.
    Sharma V; Sharma M; Dhull D; Sharma Y; Kaushik S; Kaushik S
    Can J Microbiol; 2020 Feb; 66(2):87-98. PubMed ID: 31682478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing drugs for use against Zika virus infection.
    Devillers J
    SAR QSAR Environ Res; 2018 Feb; 29(2):103-115. PubMed ID: 29299939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Computational Methods to Discover New NS2B-NS3 Inhibitors Useful Against Dengue and Zika Viruses.
    Dos Santos Nascimento IJ; da Silva Rodrigues ÉE; da Silva MF; de Araújo-Júnior JX; de Moura RO
    Curr Top Med Chem; 2022; 22(29):2435-2462. PubMed ID: 36415099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zika virus pathogenesis and current therapeutic advances.
    Mwaliko C; Nyaruaba R; Zhao L; Atoni E; Karungu S; Mwau M; Lavillette D; Xia H; Yuan Z
    Pathog Glob Health; 2021 Feb; 115(1):21-39. PubMed ID: 33191867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.
    Han Y; Mesplède T
    Expert Opin Investig Drugs; 2018 Dec; 27(12):951-962. PubMed ID: 30430882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.
    Saiz JC; Oya NJ; Blázquez AB; Escribano-Romero E; Martín-Acebes MA
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30149598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zika Virus: Emergence, Phylogenetics, Challenges, and Opportunities.
    Rajah MM; Pardy RD; Condotta SA; Richer MJ; Sagan SM
    ACS Infect Dis; 2016 Nov; 2(11):763-772. PubMed ID: 27704772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice.
    Li C; Zhu X; Ji X; Quanquin N; Deng YQ; Tian M; Aliyari R; Zuo X; Yuan L; Afridi SK; Li XF; Jung JU; Nielsen-Saines K; Qin FX; Qin CF; Xu Z; Cheng G
    EBioMedicine; 2017 Oct; 24():189-194. PubMed ID: 29033372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent trends in ZikV research: A step away from cure.
    Alam A; Imam N; Farooqui A; Ali S; Malik MZ; Ishrat R
    Biomed Pharmacother; 2017 Jul; 91():1152-1159. PubMed ID: 28531943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.